What is the appropriate evaluation and management for a 55-year-old man with persistent dizziness despite meclizine (antihistamine) therapy during a telehealth encounter?

Stop Meclizine and Perform Targeted History to Identify the Underlying Cause

Meclizine should not be routinely used for dizziness and is likely ineffective for this patient's condition 1. The medication offers no benefit for most causes of dizziness and is associated with increased fall risk (hazard ratio 2.94 in adults 18-64 years; 2.54 in those ≥65 years) 2.

Immediate Telehealth Assessment Strategy

Critical History Questions (Timing and Triggers Framework)

Ask these specific questions to categorize the dizziness syndrome 1:

Timing:

• How long does each episode last? (Seconds, minutes, hours, or days?)
• Is the dizziness constant or does it come and go?
• When did it start?

Triggers:

• Does rolling over in bed, looking up, or bending down trigger the dizziness?
• Does it happen with specific head positions or movements?
• Or does it occur spontaneously without any trigger?

Associated symptoms:

• Any hearing loss, ear fullness, or tinnitus?
• Any headache history or photophobia?
• Any neurologic symptoms (weakness, numbness, double vision, slurred speech)?

Diagnostic Framework Based on Responses

If triggered by position changes and lasts <1 minute: This is benign paroxysmal positional vertigo (BPPV) until proven otherwise 1. Meclizine is specifically ineffective for BPPV 1. The patient needs:

• Dix-Hallpike testing (can be guided via telehealth with clear instructions) 3
• Epley maneuver (canalith repositioning) - this is the definitive treatment with 78.6-93.3% improvement rates versus 30.8% with medication alone 1
• Consider in-person visit or vestibular therapy referral for proper maneuver execution

If spontaneous episodes lasting minutes to hours: Consider vestibular migraine or Ménière's disease 1. Requires different management than BPPV.

If constant dizziness lasting days: Consider vestibular neuritis, labyrinthitis, or posterior circulation stroke 1. This requires urgent evaluation, potentially in-person or emergency department.

If chronic (weeks to months): May represent incomplete vestibular compensation, medication side effects, anxiety disorder, or persistent postural-perceptual dizziness 4. Vestibular rehabilitation is indicated, not vestibular suppressants 4.

What to Do Now

1. Discontinue meclizine - it provides no therapeutic benefit and increases fall risk 1, 2

2. Categorize the dizziness using the timing/trigger questions above

3. For suspected BPPV (most common in this age group):

   • Attempt to guide Dix-Hallpike testing via video if patient has assistance
   • Refer for in-person Epley maneuver or vestibular therapy
   • Educate that this is highly treatable with physical maneuvers, not medication

4. For other patterns:

   • Vestibular migraine: Consider migraine prophylaxis
   • Red flags (neurologic symptoms, acute persistent vertigo): Arrange urgent in-person evaluation
   • Chronic symptoms: Refer to vestibular rehabilitation 4

Critical Pitfalls to Avoid

• Do not order brain imaging unless there are focal neurologic deficits or acute vestibular syndrome. CT has <1% diagnostic yield for isolated dizziness 5. MRI has only 4% yield for nonspecific dizziness 5.

• Do not continue vestibular suppressants beyond acute symptom management (severe nausea/vomiting only) 1. They impede vestibular compensation and increase fall risk 2, 4.

• Do not assume all dizziness is the same - the timing and trigger framework is essential for appropriate management 1.

The evidence strongly indicates that meclizine represents guideline-discordant care for dizziness 2, 3. The patient's lack of response is expected, as the medication was never appropriate first-line therapy. Focus on identifying the specific vestibular syndrome through structured history-taking to guide definitive treatment.